Enhanced Group Stages Drug-Open Competition Following $1.2 Billion IPO

Enhanced Group, Inc., a newly public company valued at $1.2 billion, hosted its inaugural "Enhanced Games" in Las Vegas over the weekend, staging an athletic competition where participants openly used performance-enhancing drugs under medical supervision. The event, held on May 24-25, 2026, served as a public launchpad for the company's broader business of selling peptides and hormone therapies. Founded by veterans of crypto and biotech and backed by investors including Peter Thiel and Balaji Srinivasan, Enhanced Group recently went public. The competition paid athletes appearance fees and offered up to $1 million for breaking world records, with Greek swimmer Kristian Gkolomeev setting a new mark in the 50-meter freestyle. The spectacle drew 200 journalists for what critics, including the U.S. Anti-Doping Agency, derided as a "clown show that puts profit over people." CEO Maximilian Martin framed the event as a safer alternative to widespread, unregulated doping, positioning the company within a peptide market he estimates serves 85 million Americans. The event comes as the industry anticipates potential regulatory shifts, with the FDA’s pharmaceutical advisory committee scheduled for July 2026 to consider loosening restrictions on certain peptides, a move supported by U.S. Health Secretary Robert F. Kennedy Jr. Enhanced Group recently partnered with Rezolve Ai to launch a digital telehealth platform for its treatments.